|Bid||132.96 x 1200|
|Ask||139.19 x 800|
|Day's range||135.29 - 139.34|
|52-week range||112.07 - 305.21|
|Beta (5Y monthly)||0.98|
|PE ratio (TTM)||35.80|
|Earnings date||25 Jul 2022 - 29 Jul 2022|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||23 Nov 2012|
|1y target est||145.75|
Patterson Companies (PDCO) continues to benefit from its strength in the Animal Health business and robust product portfolio. However, stiff competition remains a woe.
BD's (BDX) announcement of the implementation of BD HealthSight brings together timely monitoring to support the early detection of emerging healthcare infections, thereby improving patient care.
Inari Medical (NARI) continues to benefit from its commitment toward understanding the venous system. However, dependency on the wide adoption of products is a woe.